Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
June 5 (Reuters) - Phaxiam Therapeutics SA PHXM.PA: PHAXIAM THERAPEUTICS: NEW POSTPONEMENT OF THE OFFER REVIEW HEARING Source text: ID:nBw78K2xna Further company coverage: PHXM.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure